We further used GM and MX-based methods to detect biomarkers that are associated with the Alzheimer’s disease-related PET-imaging trait and the Parkinson’s disease-related T-tau of cerebrospinal fluid. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.